Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) has earned an average recommendation of “Buy” from the seven research firms that are currently covering the firm, MarketBeat.com reports. Seven analysts have rated the stock with a buy recommendation. The average 1-year price target among brokers that have issued ratings on the stock in the last […]
SAN FRANCISCO, Feb. 02, 2024 (GLOBE NEWSWIRE) Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted
Olema Pharmaceuticals (NASDAQ:OLMA) Now Covered by Citigroup themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
SAN FRANCISCO, Feb. 02, 2024 Olema Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for.
Analysts at Citigroup started coverage on shares of Olema Pharmaceuticals (NASDAQ:OLMA – Get Free Report) in a report released on Tuesday, Marketbeat reports. The firm set a “buy” rating and a $20.00 price target on the stock. Citigroup’s price target points to a potential upside of 72.12% from the company’s current price. Separately, HC Wainwright […]